Neutralizing antibody

Jun 15, 2020

Ethos Laboratories to Offer World's First Quantitative Surrogate Viral Neutralization Test to Evaluate COVID-19 Protective Immunity in the USA

Mar 25, 2020

Berkeley Lights Announces the Global Emerging Pathogen Antibody Discovery Consortium (GEPAD) to Attack COVID-19 and Other Viruses

Jan 28, 2020

WuXi Biologics Enables Development of Multiple Neutralizing Antibodies for Novel Coronavirus

Jan 07, 2020

Absolute Antibody Launches VivopureX(TM) Recombinant Antibodies for In Vivo Research

Jun 25, 2019

Halozyme Announces CRADA With National Institute of Allergy and Infectious Diseases For Use Of ENHANZE® Drug Delivery Technology

Oct 22, 2018

IAVI and Serum Institute of India to Develop and Manufacture Globally Affordable and Accessible Antibody Products for HIV

Oct 09, 2018

IAVI Announces Clinical Trial of Next-Generation HIV Vaccine Candidate Designed to Induce Antibodies to Block HIV Infection

Jun 12, 2018

GenScript Supports the Development of a Novel HIV Vaccine

Mar 13, 2018

Targeting HIV: Moving closer to a potential cure

Jul 25, 2017

Frontier Biotech licenses 3BNC117, a novel broad-spectrum HIV neutralizing antibody